Latest Articles

Publication Date
Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis - ca.proactiveinvestors.com

Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis ca.proactiveinvestors.com

Published: Oct. 31, 2024, 5:16 p.m.
Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis - Proactive financial news

Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis Proactive financial news

Published: Oct. 31, 2024, 5:16 p.m.
Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis - Proactive Investors USA

Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis Proactive Investors USA

Published: Oct. 31, 2024, 5:16 p.m.
New campaign for endometriosis research headed by Scottish entrepreneur - Deadline News

New campaign for endometriosis research headed by Scottish entrepreneur Deadline News

Published: Oct. 31, 2024, 3:02 p.m.
Women with underactive thyroids are being told they are menopausal or depressed - MSN

Women with underactive thyroids are being told they are menopausal or depressed MSN

Published: Oct. 31, 2024, 11:26 a.m.
Blocked fallopian tubes and infertility: Causes, treatment tips for woman to boost pregnancy chances - Hindustan Times

Blocked fallopian tubes and infertility: Causes, treatment tips for woman to boost pregnancy chances Hindustan Times

Published: Oct. 31, 2024, 10:44 a.m.
Endometriosis Market Expected to Achieve a USD 3.10 Billion Valuation by 2030 - openPR

Endometriosis Market Expected to Achieve a USD 3.10 Billion Valuation by 2030 openPR

Published: Oct. 31, 2024, 6:51 a.m.
SR-16234, a Unique Selective Estrogen Receptor Modulator, Suppressed Proliferation and Pain-Related Factor Expression by Inhibition of the Nuclear Factor-kappa B Pathway in Endometriotic Stromal Cells.

What is the effect of SR-16234 (SR), a selective estrogen receptor (ER) modulator, on human endometriotic stromal cells (ESCs)?

Published: Oct. 31, 2024, midnight
MMP-9 as a clinical marker for endometriosis: a meta-analysis and bioinformatics analysis.

This study systematically evaluated the potential efficacy of serum matrix metalloproteinase-9 (MMP-9) concentration as a diagnostic marker for endometriosis through meta-analysis. Early and accurate diagnosis of endometriosis, a common gynecological …

Published: Oct. 31, 2024, midnight
Investigating the metabolomic pathways in female reproductive endocrine disorders: a Mendelian randomization study.

Reproductive endocrine disorders (RED), including polycystic ovary syndrome (PCOS), endometriosis (EMs), and female infertility (FI), significantly affect women's health globally, with varying prevalence across different regions. These conditions can be …

Published: Oct. 31, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!